日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Severe Drug-Induced Interstitial Lung Disease After Administration of Osimertinib as Adjuvant Treatment for Resected EGFR-Mutated NSCLC: A Case Report

奥希替尼辅助治疗EGFR突变型非小细胞肺癌切除术后发生严重药物性间质性肺病:病例报告

Mitsuya, Sho; Arai, Masahiro; Kanaoka, Kiyoe; Funamoto, Tomoya; Tsuji, Hiroyuki; Tsuruoka, Kenjiro; Matsunaga, Ninso; Nakamura, Takahiko; Tamura, Yosuke; Imanishi, Masafumi; Ikeda, Soichiro; Imagawa, Akihisa; Fujisaka, Yasuhito

The cytotoxicity of gefitinib on patient‑derived induced pluripotent stem cells reflects gefitinib‑induced liver injury in the clinical setting

吉非替尼对患者来源的诱导性多能干细胞的细胞毒性反映了吉非替尼在临床环境中诱发的肝损伤

Yasuhito Fujisaka, Takatoshi Nakagawa, Kiichiro Tomoda, Marina Watanabe, Ninso Matsunaga, Yosuke Tamura, Soichiro Ikeda, Akihisa Imagawa, Michio Asahi